2453 related articles for article (PubMed ID: 18948947)
1. Somatic mutations affect key pathways in lung adenocarcinoma.
Ding L; Getz G; Wheeler DA; Mardis ER; McLellan MD; Cibulskis K; Sougnez C; Greulich H; Muzny DM; Morgan MB; Fulton L; Fulton RS; Zhang Q; Wendl MC; Lawrence MS; Larson DE; Chen K; Dooling DJ; Sabo A; Hawes AC; Shen H; Jhangiani SN; Lewis LR; Hall O; Zhu Y; Mathew T; Ren Y; Yao J; Scherer SE; Clerc K; Metcalf GA; Ng B; Milosavljevic A; Gonzalez-Garay ML; Osborne JR; Meyer R; Shi X; Tang Y; Koboldt DC; Lin L; Abbott R; Miner TL; Pohl C; Fewell G; Haipek C; Schmidt H; Dunford-Shore BH; Kraja A; Crosby SD; Sawyer CS; Vickery T; Sander S; Robinson J; Winckler W; Baldwin J; Chirieac LR; Dutt A; Fennell T; Hanna M; Johnson BE; Onofrio RC; Thomas RK; Tonon G; Weir BA; Zhao X; Ziaugra L; Zody MC; Giordano T; Orringer MB; Roth JA; Spitz MR; Wistuba II; Ozenberger B; Good PJ; Chang AC; Beer DG; Watson MA; Ladanyi M; Broderick S; Yoshizawa A; Travis WD; Pao W; Province MA; Weinstock GM; Varmus HE; Gabriel SB; Lander ES; Gibbs RA; Meyerson M; Wilson RK
Nature; 2008 Oct; 455(7216):1069-75. PubMed ID: 18948947
[TBL] [Abstract][Full Text] [Related]
2. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.
Kohno T; Otsuka A; Girard L; Sato M; Iwakawa R; Ogiwara H; Sanchez-Cespedes M; Minna JD; Yokota J
Genes Chromosomes Cancer; 2010 Apr; 49(4):342-52. PubMed ID: 20073072
[TBL] [Abstract][Full Text] [Related]
3. Mutation Profile of Resected
Zhao ZR; Lin YB; Ng CSH; Zhang R; Wu X; Ou Q; Chen W; Zhou WJ; Lin YB; Su XD; Shao YW; Long H
Oncologist; 2019 Oct; 24(10):1368-1374. PubMed ID: 30872465
[TBL] [Abstract][Full Text] [Related]
4. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
[TBL] [Abstract][Full Text] [Related]
6. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.
Finberg KE; Sequist LV; Joshi VA; Muzikansky A; Miller JM; Han M; Beheshti J; Chirieac LR; Mark EJ; Iafrate AJ
J Mol Diagn; 2007 Jul; 9(3):320-6. PubMed ID: 17591931
[TBL] [Abstract][Full Text] [Related]
7. The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis.
Lahtela J; Pradhan B; Närhi K; Hemmes A; Särkioja M; Kovanen PE; Brown A; Verschuren EW
Dis Model Mech; 2015 Apr; 8(4):393-401. PubMed ID: 25713296
[TBL] [Abstract][Full Text] [Related]
8. Characterization of adenocarcinoma of the lung in a familial adenomatous polyposis patient.
Shinmura K; Suzuki M; Yamada H; Tao H; Goto M; Kamo T; Nagura K; Kageyama S; Kato M; Ogawa S; Maekawa M; Takamochi K; Suzuki K; Nakamura T; Sugimura H
Pathol Int; 2008 Nov; 58(11):706-12. PubMed ID: 18844936
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.
Blons H; Côté JF; Le Corre D; Riquet M; Fabre-Guilevin E; Laurent-Puig P; Danel C
Am J Surg Pathol; 2006 Oct; 30(10):1309-15. PubMed ID: 17001163
[TBL] [Abstract][Full Text] [Related]
10. Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.
Brachtel EF; Iafrate AJ; Mark EJ; Deshpande V
Diagn Cytopathol; 2007 May; 35(5):257-62. PubMed ID: 17427221
[TBL] [Abstract][Full Text] [Related]
11. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.
Manceau G; Letouzé E; Guichard C; Didelot A; Cazes A; Corté H; Fabre E; Pallier K; Imbeaud S; Le Pimpec-Barthes F; Zucman-Rossi J; Laurent-Puig P; Blons H
Int J Cancer; 2013 May; 132(9):2217-21. PubMed ID: 23047306
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.
Marks JL; McLellan MD; Zakowski MF; Lash AE; Kasai Y; Broderick S; Sarkaria IS; Pham D; Singh B; Miner TL; Fewell GA; Fulton LL; Mardis ER; Wilson RK; Kris MG; Rusch VW; Varmus H; Pao W
PLoS One; 2007 May; 2(5):e426. PubMed ID: 17487277
[TBL] [Abstract][Full Text] [Related]
13. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
[TBL] [Abstract][Full Text] [Related]
14. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between mutations of epidermal growth factor receptor gene and clinicopathologic features of non-small cell lung cancers].
Wang F; Fu S; Tang T; Deng L; Zhang X; Li YZ; Shao JY
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):664-6. PubMed ID: 22321543
[TBL] [Abstract][Full Text] [Related]
16. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].
Fan MJ; Li HG; Lü ZQ; Zhang HZ; Shen XM
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547
[TBL] [Abstract][Full Text] [Related]
17. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive molecular profiling of lung adenocarcinoma.
Cancer Genome Atlas Research Network
Nature; 2014 Jul; 511(7511):543-50. PubMed ID: 25079552
[TBL] [Abstract][Full Text] [Related]
19. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma.
Yatabe Y; Kosaka T; Takahashi T; Mitsudomi T
Am J Surg Pathol; 2005 May; 29(5):633-9. PubMed ID: 15832087
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
